EXPLAINED: 11 | Vintage Vibes

Family warn parents to look out for 'obvious spots' after boy, 5, diagnosed with brain tumour

Their 5 year old is going through chemotherapy and his vision will be affected for the rest of his life

Nottingham Post · Sep 5, 2022

New womb cancer test could cut diagnosis time and reduce need for procedures

New research published in the Journal of Clinical Oncology has found that low-cost PCR test that took samples from the cervix or vagina successfully detected womb cancer.

Edinburgh Live · Aug 25, 2022

Tech & Science Daily: Womb cancer 2023 test breakthrough ‘cuts diagnosis time’

Tech & Science Daily meets first author Dr Chiara Herzog, researcher at Innsbruck’s European Translational Oncology Prevention and Screening Institute, on the new treatment.

Evening Standard · Aug 25, 2022

'Great relief': ACT govt signals intention to gynaecology oncology unit

Canberra Health Services has advertised for a gynaecological oncologist.

The Canberra Times · Aug 9, 2022

Physician heal thyself? After 4 years of treatment for stage 4 cancer I just wanted some encouraging words from my oncologist

My oncologist has one of those little motivational prints hanging on his waiting room wall, with the simple statement, “Trust Your Instincts”. One day, bored with the long purgatory of the waiting room, I tweet this news to the world with the observation: “If I trusted my instincts, I’d run…

The Conversation · Aug 3, 2022

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ rejection in patients receiving a kidney transplant. Eledon shares traded in a range of $2.89 to $3.16 on a day volume of 31.27 thousand…

Benzinga · Aug 1, 2022

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Aug 1, 2022

Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket

Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share.

Benzinga · Aug 1, 2022

July 30 — Remembering the Founder of the Cancer Institute (WIA), Dr. Muthulakshmi Reddy

Dr. Muthulakshmi Reddy made several appeals to set up a specialized cancer centre in the city of Madras.

The Hindu · Jul 29, 2022

Coimbatore oncologist launches a digital flip book to create tobacco awareness

A 15-page digital flip book launched as a part of an ongoing monthly campaign urges people to quit tobacco for their own health and the health of the environment 

The Hindu · Jul 29, 2022